2025 Webinar Series: Translating Advanced Therapies into Practice: The Case of SoHO Establishments in Europe (Group)

Includes a Live Web Event on 09/10/2025 at 2:00 PM (EDT)

Description: Join us on September 10 for “Translating Advanced Therapies into Practice: The Case of SoHO Establishments in Europe,” a webinar spotlighting how SoHO (Substances of Human Origin) establishments in Europe are moving innovative therapies from the lab to clinical application. Featuring real-world examples from Banc de Sang i Teixits (BST), this session will explore advancements in both allogeneic and autologous therapies, emerging strategies in development, and early experiences with combined therapeutic approaches. Learn how institutions like BST are bridging the gap between innovation and patient care, and what it means for the future of tissue-based therapies. Ideal for professionals across the tissue banking spectrum, from recovery and processing to quality, compliance, and education.

Target Audience: This webinar is for tissue banking professionals involved in all aspects of the donation, recovery, processing, evaluation, and distribution of human tissue including technical specialists, quality and compliance personnel, medical directors and educators.

Joaquim Vives, PhD

Investigador sènior, Cap de Grup

Banc de Sang i Teixits

Dr. Joaquim Vives is a biochemist with a PhD in Biochemistry and over two decades of experience in biotechnology and advanced therapy development. He leads the Research Group for ATMP Development at Banc de Sang i Teixits (Barcelona), where his work focuses on clinical-grade cell production, 3D tissue constructs, in vivo regeneration models, and biomarker validation.

Dr. Vives has authored 70+ peer-reviewed publications (h-index 27) and is the inventor of 3 patents. He has supervised 8 PhD graduates, with 4 more in progress, and actively lectures at the Universitat Autònoma de Barcelona, where he co-coordinates a joint Master’s program with Leiden University Medical Centre.

He is the coordinator of the COST Action BTCs4ATMP network, aimed at standardizing SoHO processing for ATMP production, and a leader in EU-funded education projects such as ASIA-TRANSMED Erasmus+. A recognized voice in the field, Dr. Vives is a TEDx speaker, former treasurer of ISCT’s European Committee, and editorial board member for Cytotherapy. He also coordinates ESACT’s annual training course on cell and gene therapy manufacturing.